| __timestamp | Travere Therapeutics, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 570979 | 54823000000 |
| Thursday, January 1, 2015 | 2185000 | 76691000000 |
| Friday, January 1, 2016 | 4554000 | 87477000000 |
| Sunday, January 1, 2017 | 3605000 | 89052000000 |
| Monday, January 1, 2018 | 5527000 | 100745000000 |
| Tuesday, January 1, 2019 | 5234000 | 91915000000 |
| Wednesday, January 1, 2020 | 6126000 | 95905000000 |
| Friday, January 1, 2021 | 6784000 | 104442000000 |
| Saturday, January 1, 2022 | 7592000 | 104437000000 |
| Sunday, January 1, 2023 | 11450000 | 112009000000 |
| Monday, January 1, 2024 | 121134000000 |
Infusing magic into the data realm
In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding cost structures is crucial. Walgreens Boots Alliance, Inc., a retail giant, and Travere Therapeutics, Inc., a niche pharmaceutical player, present a fascinating study in contrasts. From 2014 to 2023, Walgreens consistently reported a cost of revenue exceeding $50 billion annually, peaking at approximately $112 billion in 2023. This reflects its expansive retail operations and global reach. In contrast, Travere Therapeutics, with its specialized focus, saw its cost of revenue grow from a modest $0.57 million in 2014 to $11.45 million in 2023, marking a staggering increase of nearly 1,900%. This growth underscores Travere's expanding footprint in the pharmaceutical industry. Notably, data for 2024 is missing for Travere, highlighting potential reporting gaps. This comparative analysis offers insights into how scale and specialization impact financial strategies in these industries.
Analyzing Cost of Revenue: Novo Nordisk A/S and Travere Therapeutics, Inc.
Cost of Revenue Trends: Johnson & Johnson vs Walgreens Boots Alliance, Inc.
Cost of Revenue Comparison: Amgen Inc. vs Walgreens Boots Alliance, Inc.
Comparing Cost of Revenue Efficiency: Bristol-Myers Squibb Company vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Zoetis Inc. vs Walgreens Boots Alliance, Inc.
Analyzing Cost of Revenue: Neurocrine Biosciences, Inc. and Travere Therapeutics, Inc.
Cost of Revenue Trends: Bio-Techne Corporation vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Amneal Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Walgreens Boots Alliance, Inc. vs ADMA Biologics, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Vericel Corporation's Expenses
ACADIA Pharmaceuticals Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored